Rituximab vs Rosuvastatin

## Rituximab vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Rosuvastatin**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

**Rosuvastatin**: Competitive inhibitor of HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Rosuvastatin — 19 hours.

## Chemical Properties

**Molecular Formula**: Rituximab — N/A; Rosuvastatin — C22H28FN3O6S.

**Molecular Weight**: Rituximab — N/A; Rosuvastatin — 481.5390 g/mol.

**Type**: Rituximab — Antibody; Rosuvastatin — Small molecule.